AzTrials
AzTrials

Hypothermia; AnesthesiaNCT03630887

Prevention of Perioperative Hypothermia in Patients Submitted to Transurethral Resection

A study testing WarmTouch Model 5900, Covidien Ltd, Mansfield, USA in people with Hypothermia; Anesthesia and Perioperative/Postoperative Complications, run by Hospital Universitario de Gran Canaria Doctor Negrín at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hypothermia is a frequent perioperative complication. When the negative effects of anesthesia on temperature are aggravated by other factors, such as glycine infusion in transurethral resection, temperature can decrease even more. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
WarmTouch Model 5900, Covidien Ltd, Mansfield, USA
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
297 participants
Where
1 siteSpain
Study dates
14 Aug 2018to 31 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing elective Transurethral resection under general or spinal anesthesia.
  • Patients older tan 18 years old.
  • American Society of Anesthesiologists physical status classification I - III.
  • Absence of cognitive impairment.
  • Written informed consent before enrollment.

Who cannot join

  • American Society of Anesthesiologists physical status classification I - III.
  • Pregnancy.
  • Active infection.
  • Intake of antipyretics within 24 hours before surgery.
  • Neuropathy.
  • Thyroid disorders.
Show all 9Show fewer
  • Peripheral vascular disease.
  • Skin lesions.
  • History of hypersensitivity to skin contact devices.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Ángel Becerra

    Las Palmas de Gran Canaria, Las Palmas, 35019

Other trials in Spain

About this study

Hypothermia is a frequent perioperative complication. When the negative effects of anesthesia on temperature are aggravated by other factors, such as glycine infusion in transurethral resection, temperature can decrease even more. Preoperative warming prevents hypothermia, lowering the temperature gradient between core and peripheral compartments and reducing thermal redistribution. The most recent clinical practice guidelines advocate for active prewarming before induction of general anaesthesia since it is very effective in preventing perioperative hypothermia. However, the ideal warming time prior to the induction of anesthesia has long been investigated. This study aims to evaluate the optimal time period of preoperative forced-air warming to reduce the incidence of hypothermia at the end of surgery in patients submitted to transurethral resection. This is a clinical trial comparing different time periods of prewarming in patients submitted to undergo elective transurethral resection. We will compare different time periods: 0 minutes (control group), 15 minutes, 30 minutes and 45 minutes. 144 patients are going to be included in this study (36 patients in each group). Measurement of temperature will be performed using a tympanic thermometer. Patients will be followed throughout their hospital admission. Data will be recorded using a validated instrument and will be analysed using the statistics program R Core Team.

Read the detailed description

Maintaining patient's temperature above 36 grades Celsius throughout the perioperative period is challenging. Thus, it is essential to monitor temperature in order to be able to take measures to avoid the appearance of hypothermia. Once the temperature has decreased, its treatment is difficult since the application of heat to the body surface takes a long time to reach the core thermal compartment. Intraoperative warming alone cannot avoid postoperative hypothermia. The application of forced-air warming system during the preoperative period has been shown to be the most effective measure to prevent hypothermia and maintain intraoperative normothermia. However, it would not be efficient to provide a long-time prewarming in short-term surgical procedures. Thus, the ideal warming time prior to the induction of anesthesia has long been investigated. Due to the searching of optimal prewarming time and the lack of evidence about the efficiency of prewarming in patients submitted to transurethral resection, the conductance of this clinical trial is justified.

Being tested
WarmTouch Model 5900, Covidien Ltd, Mansfield, USA
Keywords
Prewarming, Tympanic temperature, Transurethral Resection
Medical subject headings
Hypothermia, Postoperative Complications, Body Temperature Changes, Transurethral resection syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WarmTouch Model 5900, Covidien Ltd, Mansfield, USADevice

    Forced-air warming will be applied in the preanesthetic room during different time periods.

Study groups in NCT03630887
Study groupRoleWhat they receive
ControlNo interventionNon-active prewarming. Patients will be actively warmed during the intraoperative period. Tympanic thermometer (Genius 2 Tympanic Thermometer and Base, Covidien Ltd, Mansfield, USA) will be used to measure the temperature throughout the perioperative period.
Prewarming during 15 minutesExperimentalActive Prewarming will be performed during 15 minutes, using a forced-air blanket (WarmTouch lower body blanket, Covidien Ltd, Mansfield, USA) over the whole body and connected to a forced-air warmer (WarmTouch Model 5900, Covidien Ltd, Mansfield, USA). Patients will be actively warmed during the intraoperative period. Tympanic thermometer (Genius 2 Tympanic Thermometer and Base, Covidien Ltd, Mansfield, USA) will be used to measure the temperature throughout the perioperative period.
Receives: Device: WarmTouch Model 5900, Covidien Ltd, Mansfield, USA
Prewarming during 30 minutesExperimentalActive Prewarming will be performed during 30 minutes, using a forced-air blanket (WarmTouch lower body blanket, Covidien Ltd, Mansfield, USA) over the whole body and connected to a forced-air warmer (WarmTouch Model 5900, Covidien Ltd, Mansfield, USA). Patients will be actively warmed during the intraoperative period. Tympanic thermometer (Genius 2 Tympanic Thermometer and Base, Covidien Ltd, Mansfield, USA) will be used to measure the temperature throughout the perioperative period.
Receives: Device: WarmTouch Model 5900, Covidien Ltd, Mansfield, USA
Prewarming during 45 minutesExperimentalActive Prewarming will be performed during 45 minutes, using a forced-air blanket (WarmTouch lower body blanket, Covidien Ltd, Mansfield, USA) over the whole body and connected to a forced-air warmer (WarmTouch Model 5900, Covidien Ltd, Mansfield, USA). Patients will be actively warmed during the intraoperative period. Tympanic thermometer (Genius 2 Tympanic Thermometer and Base, Covidien Ltd, Mansfield, USA) will be used to measure the temperature throughout the perioperative period.
Receives: Device: WarmTouch Model 5900, Covidien Ltd, Mansfield, USA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in Body Temperature among different treatment groups (using tympanic and esophageal thermometers)

    To assess the effects of prewarming in preventing drop of body temperature of patients undergoing elective transurethral resection.

    Measured: Throughout surgery, an average of 60 minutes.

Secondary outcomes (2)
  1. Length of stay in Post-Anesthetic Care Unit (in minutes)

    To assess the effect of prewarming in the length of stay in the Post-Anesthetic Care Unit of patients undergoing elective transurethral resection.

    Measured: Stay in Post-Anesthetic Care Unit, an average of 6 hours.

  2. Postoperative shivering (using a dichotomous scale: yes or no)

    To assess the effect of prewarming in the prevalence of postoperative shivering of patients undergoing elective transurethral resection.

    Measured: Immediate postoperative period, an average of 1 hour.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2018
  2. Study start14 Aug 2018
  3. Primary completion31 Oct 2018
  4. Study completion31 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will compare different time periods: 0 minutes (control group), 15 minutes, 30 minutes and 45 minutes. Sample size was authorized by IRB to be changed from 144 to 244 (61 patients per group) due to possible missing data.
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
297 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03630887
Sponsor's protocol ID
RTU-2018-153-1
Status last verified
Jun 2020
First submitted
8 Aug 2018
Last updated
11 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual Participant Data are to be shared with other researchers when required once the study is completed and global data are published.

Publications

  • Becerra A, Valencia L, Saavedra P, Rodriguez-Perez A, Villar J. Effect of prewarming on body temperature in short-term bladder or prostatic transurethral resection under general anesthesia: A randomized, double-blind, controlled trial. Sci Rep. 2021 Oct 21;11(1):20762. doi: 10.1038/s41598-021-00350-2.

    PubMed 34675311

Questions about this trial

What is this clinical trial studying?

A study testing WarmTouch Model 5900, Covidien Ltd, Mansfield, USA in people with Hypothermia; Anesthesia and Perioperative/Postoperative Complications, run by Hospital Universitario de Gran Canaria Doctor Negrín at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in Body Temperature among different treatment groups (using tympanic and esophageal thermometers) (time frame: Throughout surgery, an average of 60 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03630887, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in